SFG
INO icon

Strive Financial Group’s Inovio Pharmaceuticals INO Stock Holding History

Strive Financial Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Buy
+1
New +$1 ﹤0.01% 853
2026
Q1 		– Sell
-1
Closed -$2 – 803
2025
Q4 		$2 Buy
+1
New +$2 ﹤0.01% 727

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Strive Financial Group's INO Position: Q2 2026 in Review

Strive Financial Group opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #853 among its holdings. This is a return to the name: Strive Financial Group previously reported a position in INO as recently as Q4 2025.

Strive Financial Group first reported a position in INO in Q4 2025 and has held it in 2 quarters since. The position peaked at $2 in Q4 2025. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Strive Financial Group held 1 share of Inovio Pharmaceuticals worth $1 as of Q2 2026.
  • Inovio Pharmaceuticals was a new Strive Financial Group position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #853 holding.
  • Strive Financial Group first reported a position in Inovio Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Strive Financial Group's Inovio Pharmaceuticals position peaked at $2 in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.